[IL28 (interferon lambda3) gene polymorphisms and response to IFN-alpha treatment in patients infected with hepatitis virus C].
Labie
Dominique
D
Inserm U567, CNRS UMR 8104, Institut Cochin, 24, rue du Faubourg Saint-Jacques, 75014 Paris, France. dominique.labie@inserm.fr
Gilgenkrantz
Hélène
H